41 results match your criteria: "Valence Hospital[Affiliation]"
Int J Infect Dis
February 2025
Department of Infectious Diseases, Toulouse University Hospital, Toulouse, France; Toulouse Institute for Infectious and Inflammatory Diseases, INSERM UMR1291 - CNRS UMR5051 - Toulouse III University, Toulouse, France.
Background: Despite vaccination, patients receiving anti-CD20 monoclonal antibodies (mAbs) for multiple sclerosis (MS) or neuromyelitis optica spectrum disorders (NMOSD) have an increased risk of developing severe or protracted COVID-19. The aim of this study was to describe the effect of COVID-19 convalescent plasma (CCP) in patients with MS or NMOSD exposed to anti-CD20 and infected by SARS-CoV-2.
Methods: This French national, retrospective cohort study was conducted between November 2020 and June 2023.
Rev Med Interne
October 2024
Service de médecine interne, hôpital Saint-Antoine, AP-HP, Sorbonne université, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France. Electronic address:
J Eur Acad Dermatol Venereol
January 2025
Department of Dermatology, Valence Hospital, Valence, France.
Heliyon
May 2024
CIRI - Centre International de Recherche en Infectiologie, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon-1, Inserm U1111, CNRS UMR5308, Lyon, France.
Objectives: Appropriate tuberculosis (TB) management requires anti-TB drugs resistance detection. We assessed the performance of rapid resistance detection assays and their impact on treatment adaptation, focusing on isoniazid resistant (Hr) TB.
Methods: From 2016 to 2022, all TB cases enrolled in 3 hospitals were reviewed for phenotypic drug susceptibility testing (p-DST) and genotypic DST (g-DST) performed by rapid molecular testing, and next generation sequencing (NGS).
JAMA Oncol
June 2024
Department of Medical Oncology, Institute Mutualiste Montsouris, Paris, France.
Importance: Efficacy of second-line chemotherapy in advanced gastric or gastrooesphageal junction (GEJ) adenocarcinoma remains limited.
Ojectives: To determine the efficacy of 1 or 2 immune checkpoint inhibitors combined with FOLFIRI (leucovorin [folinic acid], fluorouracil, and irinotecan) in the treatment of advanced gastric/GEJ adenocarcinoma.
Design, Setting, And Participants: The PRODIGE 59-FFCD 1707-DURIGAST trial is a randomized, multicenter, noncomparative, phase 2 trial, conducted from August 27, 2020, and June 4, 2021, at 37 centers in France that included patients with advanced gastric/GEJ adenocarcinoma who had disease progression after platinum-based first-line chemotherapy.
J Am Acad Dermatol
July 2024
Department of Dermatology, Nice University Hospital, Nice, France. Electronic address:
Background: Studies demonstrating the potential utility of reflectance confocal microscopy (RCM) have been performed under experimental conditions.
Objective: To provide an overview of RCM practice in real-life.
Methods: A multicenter, prospective study carried out in 10 university dermatology departments in France.
Dermatol Ther (Heidelb)
December 2023
Department of Dermatology, Skin Cancer Center Hannover, Hannover Medical School, Carl-Neuberg-Str. 1, 60325, Hannover, Germany.
Introduction: At first interim analysis of KEYNOTE-629, health-related quality of life (HRQoL) with pembrolizumab was stable or improved over 48 weeks in recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC). HRQoL results from the second interim analysis in R/M or locally advanced (LA) cSCC are presented.
Methods: Patients received pembrolizumab 200 mg every 3 weeks for ≤ 2 years.
Hum Mol Genet
January 2024
Biosciences Institute, Newcastle University, International Centre for Life, Central Parkway, Newcastle upon Tyne NE1 3BZ, United Kingdom.
Developmental studies have shown that the evolutionarily conserved Wnt Planar Cell Polarity (PCP) pathway is essential for the development of a diverse range of tissues and organs including the brain, spinal cord, heart and sensory organs, as well as establishment of the left-right body axis. Germline mutations in the highly conserved PCP gene VANGL2 in humans have only been associated with central nervous system malformations, and functional testing to understand variant impact has not been performed. Here we report three new families with missense variants in VANGL2 associated with heterotaxy and congenital heart disease p.
View Article and Find Full Text PDFDiagnostics (Basel)
July 2023
Department of Interventional Radiology, CHU Dijon, 21000 Dijon, France.
Excellent outcomes of angioplasty/stenting for the post-thrombotic syndrome (PTS) have been reported, notably regarding objective criteria in the vast French SFICV cohort. Differences may exist between patient-reported and objective outcomes. We investigated this possibility by using validated scales because significative correlations are discordant in the literature between patency and patient-reported characteristics.
View Article and Find Full Text PDFCancers (Basel)
June 2023
Department of Genetics, Groupement Hospitalier EST, Hospices Civils de Lyon, 69500 Bron, France.
The use of multigene panel testing for patients with a predisposition to Hereditary Breast and Ovarian Cancer syndrome (HBOC) is increasing as the identification of mutations is useful for diagnosis and disease management. Here, we conducted a retrospective analysis of BRCA1/2 and non-BRCA gene sequencing in 4630 French HBOC suspected patients. Patients were investigated using a germline cancer panel including the 13 genes defined by The French Genetic and Cancer Group (GGC)-Unicancer.
View Article and Find Full Text PDFJ Eur Acad Dermatol Venereol
September 2023
Dermatology Department, Saint-Louis Hospital, AP-HP, Paris, France.
Background: Efficacy and safety of mogamulizumab, a monoclonal antibody directed against C-C chemokine receptor 4, were demonstrated in a previous multinational clinical trial conducted in patients with previously treated cutaneous T-cell lymphoma (CTCL): Sézary syndrome (SS) or Mycosis Fungoides (MF).
Objectives: The real-world French OMEGA study aimed to describe effectiveness and tolerability of mogamulizumab in adult patients with CTCL, overall and according to the disease (SS or MF).
Methods: In this retrospective study, patients treated with mogamulizumab for SS or MF were included from 14 French expert centres.
Eur J Dermatol
November 2022
Dermatology Unit, Nantes University Hospital, Nantes, France.
Can J Respir Ther
January 2023
Clinical Research Unit, Valence Hospital Center, Valence, France.
Introduction: The coronavirus Severe Acute Respiratory Syndrome Coronavirus Type 1 induces a severe respiratory disease, coronavirus disease 2019 (COVID-19). After Severe Acute Respiratory Syndrome Coronavirus Type 1 and Middle East Respiratory Syndrome infection, increased post-traumatic stress disorder (PTSD) rates were described.
Methods: This single-centred, prospective study aimed to evaluate the rates of PTSD in patients who were hospitalized for COVID-19.
Dig Dis Sci
April 2023
Service de Génétique des Tumeurs, Gustave Roussy, Villejuif, France.
Germline DNA alterations affecting homologous recombination pathway genes have been associated with pancreatic cancer (PC) risk. BRCA2 is the most studied gene and affects the management of PC patients and their families. Even though recent reports have suggested a similar role of germline ATM pathogenic variants (PV) in familial PC, there is still a disagreement between experts on how it could affect patient management given the lack of proper PC risk estimates.
View Article and Find Full Text PDFHum Genet
January 2023
INSERM UMR1245, UNIROUEN, Normandie Univ, F-76000, Rouen, France.
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder resulting from biallelic alterations of the SMN1 gene: deletion, gene conversion or, in rare cases, intragenic variants. The disease severity is mainly influenced by the copy number of SMN2, a nearly identical gene, which produces only low amounts of full-length (FL) mRNA. Here we describe the first example of retrotransposon insertion as a pathogenic SMN1 mutational event.
View Article and Find Full Text PDFJ Eur Acad Dermatol Venereol
October 2022
Department of Oncodermatology, Reims University Hospital, Reims, France.
J Am Coll Emerg Physicians Open
February 2022
Auvergne Rhône-Alpes Agency for Health RESCUe Network Lyon France.
Objectives: To analyze the temporal trends in thrombolysis rates after implementation of a regional emergency network for acute ischemic stroke (AIS).
Methods: We conducted a retrospective study based on a prospective multicenter observational registry. The AIS benefited from reperfusion therapy included in 1 of the 5 primary stroke units or 1 comprehensive stroke center and 37 emergency departments were included using a standardized case report form.
Clin Res Hepatol Gastroenterol
March 2022
Hepato-gastroenterology and digestive endoscopy department, Georges Pompidou European Hospital, APHP.Centre-Université de Paris, 20 rue Leblanc, 75015 Paris, France. Electronic address:
Background: European guidelines recommends the use of cold snare polypectomy (CSP) for removal of diminutive colorectal polyps (DCP). However, for DCP < 4 mm cold biopsy forceps (CBF) may be optional. We aimed to compare the efficacy of CSP with CBF for removal of DCP in routine colonoscopy.
View Article and Find Full Text PDFCardiovasc Intervent Radiol
February 2022
Department of Radiology, Nantes University Hospital, University of Medicine of Nantes, Service de Radiologie Centrale du Centre Hospitalier Universitaire de Nantes, 1, place Alexis Ricordeau, 44093, Nantes, France.
Purpose: To assess the results of endovascular treatment in a large population of patients suffering from post-thrombotic syndrome (PTS) due to iliocaval occlusive disease.
Methods: In this retrospective multi-center study, 698 patients treated by stenting for PTS in 15 French centers were analyzed. Primary, primary assisted, and secondary patency rates were assessed, and clinical efficacy was evaluated using Villalta and Chronic Venous Insufficiency Questionnaire in 20 questions (CIVIQ-20) scores.
Diagn Interv Imaging
February 2022
Department of Abdominal Radiology, Reims University Hospital, 51092 Reims, France; CRESTIC, Reims Champagne-Ardenne University, 51000 Reims, France. Electronic address:
Purpose: The purpose of this study was to determine whether texture analysis features on pretreatment contrast-enhanced computed tomography (CT) images and their evolution can predict treatment response of metastatic skin melanoma (SM) treated with anti-PD1 monoclonal antibodies.
Materials And Methods: Sixty patients (29 men, 31 women; median age, 56 years; age range: 27-91 years) with metastatic SM treated with pembrolizumab (43/60; 72%) or nivolumab (17/60; 28%) were included. Texture analysis of SM metastases was performed on baseline and first post-treatment evaluation CT examinations.
Eur J Cancer
October 2021
Department of Dermatology, Valence Hospital, Valence, France.
Commun Biol
May 2021
Centre de recherche, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.
J Eur Acad Dermatol Venereol
October 2021
Department of Dermatology, Centre Hospitalier Lyon Sud, Pierre Bénite, France.
Oral Oncol
June 2021
Department of Otolaryngology Head Neck Surgery, Faculty of Medicine Sorbonne University, Tenon Hospital, Assistance Publique Hôpitaux Paris (APHP), Paris, France; Department of Otolaryngology Head Neck Surgery, Rothschild Foundation, 75019 Paris, France.
Objective: To investigate whether palatine tonsillectomy in youth influences the risk of oropharyngeal cancers (OPC) by assessing the association between history of tonsillectomy and risk of tonsillar, base of tongue (BOT) cancer, and other head and neck cancers (HNC).
Materials And Methods: RACKAM was a case-case study comparing frequency of tonsillectomy history in individuals diagnosed with HNC from 2013 to 2018 in 15 centers across France. History of tonsillectomy was defined using combined assessment of patients' recollections and surgeons' visualizations of tonsil area.
Case Rep Neurol Med
December 2020
Neurology Department of Valence Hospital Center, Valence, France.
Objective: We report two cases of carotid dissection revealed by isolated paralysis of the ipsilateral half tongue. . First patient, 52 years old, with no particular medical or surgical history, presented with isolated paralysis of the left half tongue preceded by two weeks of moderate-intensity cervicalgia and having been the subject to cervical manipulation.
View Article and Find Full Text PDF